CHU de Liège
Liège, 4000, Belgium
NCT Number: NCT03805971
Probe based confocal laser endomicroscopy (pCLE) is a new optical endoscopic technique, generating fluorescent light emission from the tissue of interest and allowing in vivo live imaging at a cellular level ("optical biopsies"). It was first used in gastroenterology and came later to the light in pulmonary medicine and is still an experimental technique. In gastroenterology, this new investigational technique is used in Barret oesophagus, inflammatory bowel disease, pancreas cystic lesions... Nowadays, there are no data concerning usefulness of endomicroscopy in medical thoracoscopy. During thoracoscopy This new tool could help to target biopsies or help clinicians to do the right diagnosis early, allowing rapid therapeutic intervention (talc pleurodesis for example) . Furthermore, some details can be studied only during live imaging as microorganisms or bloodflows. The investigators performed an endomicroscopy to every patient needing a thoracoscopy (no matter the indication) and who agreed to participate. The pCLE features between malignant and benign pleura were compared in order to find specific criteria for malignant infiltration.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Liège, 4000, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Probe based confocal laser endomicroscope can be introduced through the working chanel of the thoracoscope. this allows the study of the pleural cavity with this new tool.
Time frame: One day.
Eleven preselected criteria were assessed in their ability to distinguish benign from malignant pleura Qualitative variables are presented in this table
Time frame: One day
Eleven preselected pCLE criteria were assessed in their ability to distinguish benign from malignant pleura.
Here are presented Mean cell size and maximum vascular diameter
Time frame: One day
Eleven preselected pCLE criteria were assessed in their ability to distinguish benign from malignant pleura.
Quantitative criteria are presented in this table. Here is presented the mean cellular density
Time frame: One day
Eleven preselected pCLE criteria were assessed in their ability to distinguish benign from malignant pleura.
Quantitative criteria are presented in this table. Here is presented the vascular density.
Time frame: One day
The investigators performing the thoracoscopy had to score the pCLE acquisition. Three level of quality were used: Good, Acceptable, Low.
University of Liege
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07118176
Adenocarcinoma, Adnexal Diseases
Los Angeles, California, United States
View Trial DetailsNCT05278975
Adenoma, Lung Diseases
Bristol, United Kingdom
View Trial DetailsNCT03881488
Adenoma, Bronchial Neoplasms
Ocala, Florida, United States
View Trial DetailsNCT04375267
Adenoma, Clinical Trial, Phase I
Gothenburg, Sweden
View Trial Details